May. 07 Gimv : Cegeka Closes 2025 With a Solid Foundation, Ready for Further Growth PU
Apr. 30 Gimv anchor investment acquires 5% stake in Azelis RE
Apr. 30 New Gimv Anchor investment: acquisition of 5% shareholding in Azelis PU
Apr. 27 Gimv : Convocation annual general meeting of May 27, 2026 PU
Apr. 27 Gimv : CV directors to be (re)appointed (CV%27s bestuurders %28ENG%29) PU
Apr. 23 Gimv : Route description (DOC10 260527 Route description Crowne Plaza %28ENG%29) PU
Mar. 25 Gimv : Complement Therapeutics Announces First Patient Dosed with CTx001 in the Phase I/II Opti-GAIN Study for Geographic Atrophy Secondary to AMD PU
Mar. 24 Gimv Obtains EUR400 Million Financing from Belgian Lenders MT
Mar. 24 Gimv secures EUR 400 million revolving credit facility RE
Mar. 24 Gimv : secures new EUR 400 million revolving credit facility to support accelerated growth ambitions PU
Mar. 11 Gimv : BioConnection is proud to announce its latest investment in further growth PU
Mar. 05 Gimv : Inkoop eigen aandelen afgerond PU
Mar. 05 Gimv : Share buyback finalized PU
Feb. 23 Gimv : Cegeka Appoints Koen Deryckere as New Chief Executive Officer PU
Feb. 20 Gimv : Aankondiging inkoop eigen aandelen in het kader van een aandelenaankoopplan PU
Feb. 20 Gimv : Announcement of share buyback in the context of a share purchase plan PU
Feb. 19 Gimv NV Reports Earnings Results for the Nine Months Ended December 31, 2025 CI
Feb. 19 Gimv 9m portfolio result at EUR 231.4 million RE
Feb. 19 Gimv : zet sterk groeitraject voort met solide resultaten Recordinvesteringen in boekjaar van 9 maanden PU
Feb. 19 Gimv : builds on strong growth to deliver solid results Record investment level in a shortened financial year of 9 months PU
Feb. 18 Gimv NV announces Annual dividend, payable on June 03, 2026 CI
Jan. 27 Gimv to Cease New Life Sciences Investments MT
Jan. 26 Gimv discontinues activities for new life sciences investments RE
Jan. 26 Gimv : verhoogt focus op strategische doelstellingen en discontinueert activiteiten voor nieuwe Life Sciences investeringen PU
Jan. 26 Gimv : increases focus on strategic objectives and discontinues activities for new Life Sciences investments PU
No results for this search